Beryl Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-496,499
Closed -$283K 357
2021
Q4
$283K Buy
+496,499
New +$255K 0.01% 341

Other funds holding LVACW

Beryl Capital Management's LVACW Position: Q1 2022 in Review

Beryl Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q1 2022, closing a stake of 496,499 shares — an estimated $283K sold.

Beryl Capital Management first reported a position in LVACW in Q4 2021 and held it in 1 quarter. The position peaked at $283K in Q4 2021. 29 funds tracked by Wall St. Rank hold LVACW as of Q1 2022.

  • Beryl Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q1 2022 after selling out during the quarter.
  • Beryl Capital Management sold 496,499 LAVA Medtech Acquisition Corp. Warrants shares in Q1 2022, an estimated $283K.
  • Beryl Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 1 quarter.
  • Beryl Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $283K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q1 2022.

Based on Beryl Capital Management's 13F filing for Q1 2022, filed 16 May 2022.